Search For "drug"
Black Fungus: India receives 50,000 vials of Amphotericin-B from US Pharma
Updated : 5 years, 2 months ago IST
Mumbai (Maharashtra) [India], May 28 (ANI): India on Friday received 50,000 vials of Amphotericin-B, the drug used for the treatment of Mucormycosis, commonly known as Black Fungus, at Mumbai Airport.
Read More
DRDO's anti-COVID drug priced at Rs 990 per sachet; Centre, states to get
Updated : 5 years, 2 months ago IST
New Delhi [India], May 28 (ANI): Defence Research and Development Organisation's (DRDO) anti-Covid-19 drug will be sold at Rs 990 per sachet by Dr Reddy's Laboratories (DRL), officials said on Friday. The Hyderabad-based pharma company, however, will provide the medicine to Centre and state
Read More
Black fungus: Uttarakhand receives 15,000 vials of Amphotericin-B
Updated : 5 years, 2 months ago IST
Dehradun (Uttarakhand) [India], May 28 (ANI): Uttarakhand has received 15,000 vials of Amphotericin-B, the drug used for treating patients with black fungus, from a Rudrapur-based pharmacy company, late on Thursday.
Read More
Priyanka Gandhi Vadra demands removal of GST from COVID related drugs, equ
Updated : 5 years, 2 months ago IST
New Delhi [India], May 28 (ANI): Ahead of the 43rd Goods and Services Tax (GST) meeting scheduled for today, Congress leader Priyanka Gandhi Vadra on Friday demanded that the centre remove GST from all life-saving medicines and equipment being used in the fight against the COVID-19 pandemic.
Read More
Black Fungus: Punjab CM orders ramp-up of alternate drugs
Updated : 5 years, 2 months ago IST
Chandigarh (Punjab) [India], May 28 (ANI): With as many as 188 cases of Mucormycosis (Black Fungus) reported in the state so far, Chief Minister Captain Amarinder Singh on Thursday ordered a ramp-up of stocks of alternate drugs to treat the disease in view of the shortage of Amphotericin.
Read More
China's Sinopharm publishes awaited COVID vaccine trial data; fails to cov
Updated : 5 years, 2 months ago IST
Beijing [China], May 27 (ANI): The Chinese drug maker Sinopharm has finally published the interim results of a phase 3 trial of its COVID-19 vaccine, however, the results do not cover some of the most vulnerable groups.
Read More
Delhi HC asks Centre to consider complete waiver of Amphotericin B import
Updated : 5 years, 2 months ago IST
New Delhi [India], May 27 (ANI): The Delhi High Court on Thursday asked the Central Government to consider a complete waiver of import duties of the drug Amphotericin B, for a limited period till the scarcity of drug is resolved in the country.
Read More
10,000 sachets of anti-COVID drug 2-DG to be available in market from toda
Updated : 5 years, 2 months ago IST
New Delhi [India], May 27 (ANI): Union Defence Minister Rajnath Singh informed that 10,000 sachets of anti-COVID drug 2-DG will be available in the market from Thursday.
Read More
TradeIndia set to organize India's first Medical and Healthcare Expo India
Updated : 5 years, 2 months ago IST
New Delhi [India], May 27 (ANI/BusinessWire India): TradeIndia, the country's leading B2B online marketplace platform, is preparing to host its ninth landmark virtual event, the Medical and Healthcare Expo India 2021.
Read More
Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibo
Updated : 5 years, 2 months ago IST
New Delhi [India], May 27 (ANI): Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID-19 infection, the pharmaceutical manufacturer informed on Thursday.
Read More
Opiate overdoses can lead to poor mental health: Study
Updated : 5 years, 2 months ago IST
Washington [US], May 27 (ANI): The opioid epidemic is taking a deadly toll on people in disproportionate clusters from Cape Cod to San Diego, according to a new study by the University of Cincinnati.
Read More
Fortis Escorts to administer monoclonal antibodies in Delhi
Updated : 5 years, 2 months ago IST
New Delhi [India], May 26 (ANI): Fortis Escorts Heart Institute in Delhi is to administer dose of COVID-19 drug cocktail with fast-acting antibodies - Casirivimab and Imdevimab - from tomorrow.
Read More